Capula Management’s Medifast MED Stock Holding History

Capula Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,400	Closed	-$778K	–	466
2023 Q3	$778K	Buy	+10,400	New	+$923K	0.02%	268
2023 Q1	–	Sell	-8,950	Closed	-$1.03M	–	848
2022 Q4	$1.03M	Buy	+8,950	New	+$1.04M	0.01%	401
2021 Q4	–	Sell	-1,393	Closed	-$268K	–	552
2021 Q3	$268K	Buy	+1,393	New	+$342K	﹤0.01%	727

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Capula Management's MED Position: Q4 2023 in Review

Capula Management sold out of Medifast (MED) in Q4 2023, closing a stake of 10,400 shares — an estimated $778K sold.

Capula Management first reported a position in MED in Q3 2021 and held it in 3 quarters. The position peaked at $1.03M in Q4 2022. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

Capula Management reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
Capula Management sold 10,400 Medifast shares in Q4 2023, an estimated $778K.
Capula Management first reported a position in Medifast in Q3 2021 and held it in 3 quarters.
Capula Management's Medifast position peaked at $1.03M in Q4 2022.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Capula Management's 13F filing for Q4 2023, filed 12 Feb 2024.